Grufity logoGrufity logo
Stocks
Funds
Screener
Sectors
Watchlists
IRMD

IRMD - iRadimed Corp Stock Price, Fair Value and News

$97.96-1.88 (-1.88%)
Market Closed

39/100

IRMD

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

39/100

IRMD

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

Price Targets

Target 1Y

$80.69

Target 3M

$94.91

Target 6M

$89.26

IRMD Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

IRMD Price Action

Last 7 days

-5.1%

Last 30 days

0.2%

Last 90 days

28.2%

Trailing 12 Months

61.4%

IRMD RSI Chart

IRMD Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

IRMD Valuation

Market Cap

1.2B

Price/Earnings (Trailing)

58.82

Price/Sales (Trailing)

15.48

EV/EBITDA

42.65

Price/Free Cashflow

84.48

IRMD Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

Price Targets

Target 1Y

$80.69

Target 3M

$94.91

Target 6M

$89.26

IRMD Fundamentals

IRMD Revenue

Revenue (TTM)

80.5M

Rev. Growth (Yr)

15.69%

Rev. Growth (Qtr)

3.88%

IRMD Earnings

Earnings (TTM)

21.2M

Earnings Growth (Yr)

10.44%

Earnings Growth (Qtr)

-3.42%

IRMD Profitability

Operating Margin

77.07%

EBT Margin

33.43%

Return on Equity

21.54%

Return on Assets

18.47%

Free Cashflow Yield

1.18%

IRMD Investor Care

Shares Dilution (1Y)

0.38%

Diluted EPS (TTM)

1.65

IRMD Alerts

  • 1 major insider sales recently.

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
202575.2M77.6M80.5M0
202467.7M69.5M71.3M73.2M
202356.5M59.9M63.0M65.6M
202244.9M47.8M50.3M53.3M
202132.3M35.3M38.5M41.8M
202038.8M36.3M34.1M31.7M
201931.8M33.6M36.0M38.5M
201825.0M26.9M28.8M30.4M
201728.7M24.4M22.4M23.1M
201633.6M35.8M35.3M32.5M
201519.1M22.0M26.4M31.6M
201412.4M13.5M14.6M15.7M
201300011.3M
Get all data in R, Python etc through our Historical Stock Data APIs

About iRadimed Corp

IRMD
IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices, and related accessories and services in the United States and internationally. It offers MRidium MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets; and MRI compatible patient vital signs monitoring system. The company also provides non-magnetic IV poles, wireless remote displays/controls, side car pump modules, dose error reduction systems, and SpO2 monitoring with sensors and accessories. It serves hospitals, acute care facilities, and outpatient imaging centers. The company sells its products through direct field sales representatives, regional sales directors, clinical support representatives, and independent distributors. IRADIMED CORPORATION was incorporated in 1992 and is headquartered in Winter Springs, Florida.
 CEO
 WEBSITEiradimed.com
 SECTORHealthcare
 INDUSTRYMedical Devices
 EMPLOYEES123

iRadimed Corp Frequently Asked Questions

IRMD is the stock ticker symbol of iRadimed Corp. Every public company that trades on a stock exchange gets a ticker symbol.

As of Wed Jan 28 2026, market cap of iRadimed Corp is 1.25 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

You can check IRMD's fair value in chart for subscribers.

The fair value guage provides a quick view whether IRMD is over valued or under valued. Whether iRadimed Corp is cheap or expensive depends on the assumptions which impact iRadimed Corp's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for IRMD.

As of Wed Jan 28 2026, IRMD's PE ratio (Price to Earnings) is 58.82 and Price to Sales (PS) ratio is 15.48. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. IRMD PE ratio will change depending on the future growth rate expectations of investors.

In the past 10 years, iRadimed Corp has provided 0.176 (multiply by 100 for percentage) rate of return.